The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Melissa Coles; Bela Toth (Profiled Author: Bela Toth)
In Vivo 2005;19(4):661-665.Abstract
Celecoxib (C), a COX-2 enzyme inhibitor, was administered at a 0.1% dose level in the diet of female Swiss Webster CFW outbred mice for life. The mice also received 1,2-dimethylhydrazine dihydrochloride (1,2-DMH) as 10 weekly subcutaneous injections at 20 μg/g body weight. The number of animals with large intestinal cancer and the total number of these cancers were 30 and 321 in the 1,2-DMH-treated group, while the corresponding figures in the C and 1,2-DMH-treated group were 29 and 156. This difference is statistically highly significant. The literature contains a limited number of publications concerning the cancer chemopreventive activity of C, particularly in mice. The present work, thus, provides additional proof in this field of interest.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Bela Toth; Melissa ColesIn Vivo 2006;20(4):453-458.
James E. Talmadge; Keith C. Hood; Lori C. Zobel; Laura R. Shafer; Melissa Coles; Bela TothInternational Immunopharmacology 2007;7(2):140-151.
Melissa Coles; Bela TothIn Vivo 2005;19(5):867-872.
Appears in this Document